Gene and Cell Therapy – News and Features

Scientists have derived embryonic stem cells by reprogramming of genetic material from skin cells while studying rhesus macaque monkeys.

The funding is allocated to Collaborative R&D projects that address one or more of the areas indicated by The Technology Strategy Board.

SpineSmith Partners has licensed the rights to all of Tissue Genesis’s patents and technologies for use in the diagnosis and treatment of the human spine.

University of Pittsburgh researchers shows effectiveness of intravenous gene therapy in protecting healthy tissues during exposure to whole-body radiation.

Company's newly discovered stem cell shows promising potential in regenerative medicine.

Researchers have demonstrated that a muscular dystrophy patient should be able to maintain a normal lifestyle if only 50 percent of the cells of the heart are healthy.

Genzyme and Sunway collaborate to manufacture, develop, and commercialize the experimental gene therapy Ad2/HIF-1a in China.

Video details promise of current adult stem cell clinical trials targeting widespread diseases such as cancer, diabetes and heart disease.

The study results provide insight into the development biology and suggest new ways to treat atherosclerosis and cancer.

Stem cell researchers Mario Capecchi, Martin Evans and Oliver Smithies won the 2007 Nobel prize for medicine or physiology for their work on gene changes in mice using embryonic cells.